突变p53的胆汁酸诱导的聚合和相分离导致了多克索鲁比辛的隔离
Harpreet Kaur1, Devansh Swadia2, Ishani Sharma1
1Chemical Biology Unit, Institute of Nano Science and Technology, Knowledge City, S.A.S Nagar, Sector-81, Mohali 140306, Punjab, India.
Biomacromolecules
|February 2, 2026
概括
二次胆汁酸在结直肠癌 (CRC) 中促进突变p53 (一种瘤抑制剂) 的聚合. 这种由多克索鲁比增强的聚合导致治疗耐药性和受损的DNA结合,这表明了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 瘤抑制剂p53中的突变是结直肠癌 (CRC) 预后不佳和治疗耐药性的关键驱动因素.
- 环境因素和瘤微环境的代谢物影响瘤的进展.
研究的目的:
- 为了研究二次胆汁酸 (石化胆汁酸[LCA]和脱氧胆汁酸[DCA]) 与CRC中的突变p53之间的相互作用.
- 了解这些相互作用如何影响p53功能和化学抵抗.
主要方法:
- 使用了表达野生型和突变p53 (R273H,R273C) 的细胞系.
- 进行生物物理研究以评估p53聚合,DNA结合和LCA结合亲和力.
- 采用成像研究来确认聚合和凝结物形成.
- 研究了多克索鲁比辛对这些相互作用的影响.
主要成果:
- 二次胆汁酸 (LCA,DCA) 显著促进R273H和R273C突变p53变体的聚合,对野生类型p53.3的影响很小.
- 多克索鲁比辛显著增强胆酸诱导的突变p53聚合.
- 在多克索鲁比的存在下,胆酸完全消除了突变p53.3的DNA结合.
- LCA与突变的p53结合,具有很高的亲和力,诱导大型寡合体组合和生物分子凝聚物.
- 胆汁酸诱导生物分子凝聚物形成,将多克索鲁比隔离,这表明化学抵抗的机制.
结论:
- 二次胆汁酸在促进结直肠癌中突变的p53聚合中发挥着至关重要的作用.
- 胆酸诱导的突变p53聚合通过破坏DNA结合和隔离化疗药物,有助于治疗耐药性.
- 针对与突变p53的胆酸相互作用,可能为p53突变CRC提供新的治疗策略.
相关概念视频
Phase-lead and Phase-lag Controllers
550
Understanding the working function of different types of controllers can be illustrated with practical analogies, such as adjusting a stereo's volume equalizer. Cranking up the bass involves a phase-lead controller, which functions as a high-pass filter, while increasing the treble uses a phase-lag controller, which acts as a low-pass filter. PD controllers, similar to high-pass filters, enhance the system's response to high-frequency components. PI controllers, akin to low-pass...
550
Time and frequency -Domain Interpretation of Phase-lead Control
454
Phase-lead controllers are commonly used in various control systems to enhance response speed and stability. Adjusting the brightness on a television screen offers a practical example of phase-lead control. When contrast is enhanced, a phase-lead controller is employed. Mathematically, phase-lead control is identified when the first parameter is smaller than the second.
The design of phase-lead control involves the strategic placement of poles and zeros to balance steady-state error and system...
The design of phase-lead control involves the strategic placement of poles and zeros to balance steady-state error and system...
454
Bile
4.2K
Bile is a crucial bodily fluid, characterized by its yellow-green color and alkaline nature. Produced in the liver, it is transported through the common hepatic duct into either the cystic duct, leading to the gallbladder, or directly into the common bile duct. The flow of bile is regulated by the sphincter of Oddi located at the entrance of the duodenum. When this sphincter is closed, bile is redirected to the gallbladder for storage and concentration.
Bile is released when dietary fats enter...
Bile is released when dietary fats enter...
4.2K
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
932
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
932
Phase Diagrams
50.2K
A phase diagram combines plots of pressure versus temperature for the liquid-gas, solid-liquid, and solid-gas phase-transition equilibria of a substance. These diagrams indicate the physical states that exist under specific conditions of pressure and temperature and also provide the pressure dependence of the phase-transition temperatures (melting points, sublimation points, boiling points). Regions or areas labeled solid, liquid, and gas represent single phases, while lines or curves represent...
50.2K
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
956
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
956


